LXRX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

LXRX

39.6
AI Score
VS
ZBIO Wins

ZBIO

55.9
AI Score

Investment Advisor Scores

LXRX

40score
Recommendation
SELL

ZBIO

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LXRX ZBIO Winner
Revenue 1.26M 1.00M LXRX
Net Income -25.30M -192.44M LXRX
Net Margin -2004.4% -19244.3% LXRX
Operating Income -25.68M -185.01M LXRX
ROE -20.6% -77.9% LXRX
ROA -8.5% -27.4% LXRX
Total Assets 297.67M 701.69M ZBIO
Cash 62.89M 196.58M ZBIO
Current Ratio 2.22 9.93 ZBIO

Relative Price Performance (Last 90 Days)

LXRX 1M: +0.0% · 3M: +3.1% ZBIO 1M: +4.2% · 3M: +62.8%

Current Technical Phase

LXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $2.30

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.2% over 20 days), RSI 59

RSI (14): 58.5 · Price: $32.29

Fundamentals Snapshot

Metric LXRX ZBIO
Market Cap
Forward P/E -12.1 -6.7
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% -1.0%
Gross Margin 0.9% -212.5%
Operating Margin -38.4% -77.7%
EPS -0.14 -9.63
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.